Table of contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Liquid Biopsy Adoption and Utilization Trends (2023-2032)
5.2 Reimbursement and Coverage Trends (2023), by Region
5.3 Pricing Trends of Liquid Biopsy Tests (2023-2032)
5.4 Technological Advancements and Research Pipeline Trends
5.5 Regulatory Trends and Policy Impacts
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Breast Cancer Liquid Biopsy Market Segmentation, by Biomarkers
7.1 Chapter Overview
7.2 Circulating Tumor Cells (CTCs)
7.2.1 Circulating Tumor Cells (CTCs) Market Trends Analysis (2020-2032)
7.2.2 Circulating Tumor Cells (CTCs) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Circulating Cell-Free DNA (cfDNA)
7.3.1 Circulating Cell-Free DNA (cfDNA) Market Trends Analysis (2020-2032)
7.3.2 Circulating Cell-Free DNA (cfDNA) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Extracellular Vesicles (EVs)
7.4.1 Extracellular Vesicles (EVs) Market Trends Analysis (2020-2032)
7.4.2 Extracellular Vesicles (EVs) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Other Circulating Biomarkers
7.5.1 Other Circulating Biomarkers Market Trends Analysis (2020-2032)
7.5.2 Other Circulating Biomarkers Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Breast Cancer Liquid Biopsy Market Segmentation, by Application
8.1 Chapter Overview
8.2 Early Detection/Screening
8.2.1 Early Detection/Screening Market Trends Analysis (2020-2032)
8.2.2 Early Detection/Screening Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Diagnosis
8.3.1 Diagnosis Market Trends Analysis (2020-2032)
8.3.2 Diagnosis Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Treatment Selection
8.4.1 Treatment Selection Market Trends Analysis (2020-2032)
8.4.2 Treatment Selection Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Monitoring
8.5.1 Monitoring Market Trends Analysis (2020-2032)
8.5.2 Monitoring Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.2.4 North America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.2.5.2 USA Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.2.6.2 Canada Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.2.7.2 Mexico Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.1.5.2 Poland Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.1.6.2 Romania Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.4 Western Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.5.2 Germany Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.6.2 France Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.7.2 UK Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.8.2 Italy Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.9.2 Spain Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.12.2 Austria Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.4 Asia Pacific Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.5.2 China Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.5.2 India Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.5.2 Japan Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.6.2 South Korea Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.2.7.2 Vietnam Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.8.2 Singapore Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.9.2 Australia Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.1.4 Middle East Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.1.5.2 UAE Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.2.4 Africa Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.6.4 Latin America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.6.5.2 Brazil Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.6.6.2 Argentina Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.6.7.2 Colombia Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Biomarkers (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Breast Cancer Liquid Biopsy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10. Company Profiles
10.1 The Menarini Group
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 NeoGenomics Laboratories
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Myriad Genetics, Inc.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Thermo Fisher Scientific, Inc.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 QIAGEN
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Biocept, Inc.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Biocept, Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Fluxion Biosciences, Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Epic Sciences, Inc.
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
